New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
07:49 EDTEWEdwards Lifesciences price target raised to $90 from $75 at Stifel
After Edwards reported higher than expected Q1 EPS, Stifel thinks the company is doing well so far in 2014. The firm expects analysts' estimates to rise gradually over time as a result of several positive catalysts. It keeps a Buy rating on the shares.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2015
09:59 EDTEWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:48 EDTEWInvestors should look at several medtech stocks, says BMO Capital
BMO Capital believes that macro issues have caused declines in medtech stocks. However, the firm thinks that the sector dealt with pricing issues years ago, while patient volumes are rising and larger cap names in the sector have "relatively stable revenue streams." BMO recommends that investors look at stocks with "reasonable multiples," such as Medtronic (MDT), those with new product pipelines such as Boston Scientific (BSX) and Edwards Lifesciences (EW), and those with small-cap product cycles, including Nevro (NVRO), NuVasive (NUVA), and Endologix (ELGX).
07:55 EDTEWEdwards Lifesciences initiated with an Outperform at Cowen
Subscribe for More Information
October 5, 2015
15:15 EDTEWStudy finds potential stroke risk with prosthetic heart valves
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use